{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T18:41:57Z","timestamp":1770230517664,"version":"3.49.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Cancer patients may have increased risk for adverse cardiac events, but our understanding of cardiovascular risk in thymic cancer patients is not clear. We sought to characterize baseline cardiometabolic risk factors before thymic cancer diagnosis and the potential association between cancer treatment and subsequent cardiac events.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This was a retrospective cohort study evaluating patients with thymic cancer from 2003 to 2020 compared to age- and sex-matched controls without cancer. Baseline cardiovascular risk factors, cancer characteristics, and incidence of cardiac events were collected from the health information exchange. Multivariable regression was used to examine the impact of cardiovascular risk factors and cancer therapies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We compared 296 patients with pathology-confirmed thymic cancer to 2,960 noncancer controls. Prior to cancer diagnosis, thymic cancer patients (TCPs) had lower prevalence of hypertension, dyslipidemia, and diabetes mellitus and similar rates of obesity, tobacco use, and pre-existing cardiovascular disease (CVD) compared to controls. After diagnosis, high-risk TCPs (&amp;gt;2 cardiovascular risk factors or pre-existing CVD) had higher risk for cardiac events (HR 3.73, 95% CI 2.88\u20134.83, <jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.001). In the first 3 years after diagnosis, TCPs had higher incidence of cardiac events (HR 1.38, 95% CI 1.01\u20131.87, <jats:italic>p<\/jats:italic>\u2009=\u20090.042). High-risk TCPs who received radiotherapy or chemotherapy had higher risk of cardiac events (HR 4.99, 95% CI 2.30\u201310.81, <jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.001; HR 6.24, 95% CI 2.84\u201313.72, <jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion\/conclusion<\/jats:title><jats:p>Compared to noncancer controls, TCPs experienced more cardiac events when adjusted for risk factors. Patients with multiple cardiovascular risk factors receiving radiotherapy or chemotherapy had higher incidence of cardiac events.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2024.1393631","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T13:45:59Z","timestamp":1725975959000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Cardiovascular disease in thymic cancer patients"],"prefix":"10.3389","volume":"11","author":[{"given":"Abhishek","family":"Khemka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suparna C.","family":"Clasen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick J.","family":"Loehrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna R.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilian","family":"Golzarri-Arroyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil S.","family":"Badve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subha V.","family":"Raman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siu L.","family":"Hui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Titus K. L.","family":"Schleyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,9,10]]},"reference":[{"key":"B1","article-title":"The American Cancer Society Medical and Editorial Content Team. Key Statistics About Thymus Cancers. Cancer.Org","year":""},{"key":"B2","doi-asserted-by":"publisher","first-page":"S304","DOI":"10.1097\/JTO.0b013e3181f20c05","article-title":"Staging system of thymoma","volume":"5","author":"Masaoka","year":"2010","journal-title":"J Thorac Oncol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.athoracsur.2012.09.006","article-title":"Thymic carcinoma: a multivariate analysis of factors predictive of survival in 290 patients","volume":"95","author":"Weksler","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"B4","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/s0003-4975(03)00555-1","article-title":"Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan","volume":"76","author":"Kondo","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"B5","doi-asserted-by":"publisher","first-page":"7571","DOI":"10.21037\/jtd-2019-thym-10","article-title":"Autoimmune disorders and paraneoplastic syndromes in thymoma","volume":"12","author":"Blum","year":"2020","journal-title":"J Thorac Dis"},{"key":"B6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ijcme.2014.08.003","article-title":"Cardiac manifestations of myasthenia gravis: a systematic review","volume":"5","author":"Shivamurthy","year":"2014","journal-title":"IJC Metab Endocr"},{"key":"B7","doi-asserted-by":"publisher","first-page":"S143","DOI":"10.1097\/JTO.0000000000000300","article-title":"Paraneoplastic disorders in thymoma patients","volume":"9","author":"Evoli","year":"2014","journal-title":"J Thorac Oncol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"7626","DOI":"10.21037\/jtd-20-818","article-title":"Multimodality approach in treatment of thymic tumors","volume":"12","author":"Turna","year":"2020","journal-title":"J Thorac Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1002\/ejhf.1252","article-title":"Cancer and heart failure, more than meets the eye: common risk factors and co-morbidities","volume":"20","author":"Anker","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1161\/CIRCULATIONAHA.115.020406","article-title":"Shared risk factors in cardiovascular disease and cancer","volume":"133","author":"Koene","year":"2016","journal-title":"Circulation"},{"key":"B11","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/ejhf.592","article-title":"2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"B12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11864-021-00869-6","article-title":"Cardiovascular complications associated with contemporary lung cancer treatments","volume":"22","author":"Sase","year":"2021","journal-title":"Curr Treat Options Oncol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1161\/CIR.0000000000000556","article-title":"Cardiovascular disease and breast cancer: where these entities intersect\u2014a scientific statement from the American Heart Association","volume":"137","author":"Mehta","year":"2018","journal-title":"Circulation"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1200\/JCO.2015.64.0409","article-title":"Cardiovascular disease among survivors of adult-onset cancer: a community-based retrospective cohort study","volume":"34","author":"Armenian","year":"2016","journal-title":"J Clin Oncol"},{"key":"B15","first-page":"328","article-title":"Pericardial effusion in a young man: a rare presentation of thymoma","volume":"22","author":"Moady","year":"2020","journal-title":"Isr Med Assoc J"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1080\/00207454.2018.1486830","article-title":"Respiratory insufficiency from myasthenia gravis and polymyositis due to malignant thymoma triggering takotsubo syndrome","volume":"128","author":"Finsterer","year":"2018","journal-title":"Int J Neurosci"},{"key":"B17","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1093\/jnen\/nly041","article-title":"Giant cell polymyositis and myocarditis in a patient with thymoma and myasthenia gravis: a postviral autoimmune process?","volume":"77","author":"Priemer","year":"2018","journal-title":"J Neuropathol Exp Neurol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e561","DOI":"10.1016\/j.athoracsur.2017.01.032","article-title":"Thymoma in the middle mediastinum with blood supply from the left main coronary artery","volume":"103","author":"Tsimpinos","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"B19","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1093\/ejcts\/ezu376","article-title":"Successful resection of thymoma directly invading the right atrium under cardiopulmonary bypass","volume":"48","author":"De Giacomo","year":"2015","journal-title":"Eur J Cardiothorac Surg"},{"key":"B20","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s11748-013-0302-9","article-title":"Post-irradiation constrictive pericarditis following thymoma treatment: a report of two cases","volume":"63","author":"Hikosaka","year":"2015","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"B21","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/JTO.0b013e31827bd931","article-title":"Characterization and management of cardiac involvement of thymic epithelial tumors","volume":"8","author":"Thomas","year":"2013","journal-title":"J Thorac Oncol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1002\/cncr.31230","article-title":"Cardiometabolic risk factors and survival after breast cancer in the women\u2019s health initiative","volume":"124","author":"Simon","year":"2018","journal-title":"Cancer"},{"key":"B23","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/B978-0-323-90802-3.00022-8","article-title":"The Indiana health information exchange","volume-title":"Health Information Exchange: Navigating and Managing a Network of Health Information Systems","author":"Overhage","year":"2023"},{"key":"B24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/hir.12127","article-title":"Utilizing an integrated infrastructure for outcomes research: a systematic review","volume":"33","author":"Dixon","year":"2016","journal-title":"Health Info Libr J"},{"key":"B25","first-page":"174","article-title":"Linkage of Indiana state cancer registry and Indiana network for patient care data","volume":"43","author":"Ruppert","year":"2016","journal-title":"J Registry Manag"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1377\/hlthaff.24.5.1214","article-title":"The Indiana network for patient care: a working local health information infrastructure. An example of a working infrastructure collaboration that links data from five health systems and hundreds of millions of entries","volume":"24","author":"McDonald","year":"2005","journal-title":"Health Aff (Millwood)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1253\/jcj.50.1288","article-title":"Twenty year autopsy statistics of myocarditis incidence in Japan","volume":"50","author":"Wakafuji","year":"1986","journal-title":"Jpn Circ J"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2050312120965752","DOI":"10.1177\/2050312120965752","article-title":"Inflammatory cytokines in the pathogenesis of cardiovascular disease and cancer","volume":"8","author":"Amin","year":"2020","journal-title":"SAGE Open Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/j.jacc.2007.06.037","article-title":"Early breast cancer therapy and cardiovascular injury","volume":"50","author":"Jones","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1001\/jamainternmed.2015.1180","article-title":"Cardiovascular disease after hodgkin lymphoma treatment: 40-year disease risk","volume":"175","author":"van Nimwegen","year":"2015","journal-title":"JAMA Intern Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1002\/hsr2.135","article-title":"Treatment for lymphoma and late cardiovascular disease risk: a systematic review and meta-analysis","volume":"2","author":"Stone","year":"2019","journal-title":"Health Sci Rep"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1161\/CIRCULATIONAHA.115.018347","article-title":"Vascular toxicities of cancer therapies: the old and the new\u2013an evolving avenue","volume":"133","author":"Herrmann","year":"2016","journal-title":"Circulation"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1161\/CIRCRESAHA.115.303633","article-title":"Cardio-oncology: an update on cardiotoxicity of cancer-related treatment","volume":"118","author":"Lenneman","year":"2016","journal-title":"Circ Res"},{"key":"B34","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1001\/jamacardio.2016.0582","article-title":"Association of atrial fibrillation and cancer","volume":"1","author":"Rahman","year":"2016","journal-title":"JAMA Cardiol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1001\/jamacardio.2016.0280","article-title":"Risk of malignant cancer among women with new-onset atrial fibrillation","volume":"1","author":"Conen","year":"2016","journal-title":"JAMA Cardiol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e0205454","DOI":"10.1371\/journal.pone.0205454","article-title":"Cancer increases the risk of atrial fibrillation during long-term follow-up (OPERA study)","volume":"13","author":"Kattelus","year":"2018","journal-title":"PLoS One"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.athoracsur.2010.01.026","article-title":"Prognostic indicators after surgery for thymoma","volume":"89","author":"Okereke","year":"2010","journal-title":"Ann Thorac Surg"},{"key":"B38","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.ijsu.2018.04.018","article-title":"The role of postoperative radiation therapy for completely resected stage III thymoma and effect of higher heart radiation dose on risk of cardiovascular disease: a retrospective cohort study","volume":"53","author":"Liao","year":"2018","journal-title":"Int J Surg"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1016\/j.jacc.2017.09.1095","article-title":"Cardiovascular complications of cancer therapy: best practices in diagnosis, prevention, and management, part 2","volume":"70","author":"Chang","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1016\/j.jacc.2017.09.1096","article-title":"Cardiovascular complications of cancer therapy: best practices in diagnosis, prevention, and management, part 1","volume":"70","author":"Chang","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3389\/fonc.2015.00039","article-title":"Radiation-induced heart disease: pathologic abnormalities and putative mechanisms","volume":"5","author":"Taunk","year":"2015","journal-title":"Front Oncol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e021686","DOI":"10.1161\/JAHA.121.021686","article-title":"Radiation-induced cardiovascular disease: review of an underrecognized pathology","volume":"10","author":"Belzile-Dugas","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e005633","DOI":"10.1161\/JAHA.117.005633","article-title":"Long-Term cardiovascular risk after radiotherapy in women with breast cancer","volume":"6","author":"Cheng","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"B44","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jaccao.2020.11.012","article-title":"The evolving immunotherapy landscape and the epidemiology, diagnosis, and management of cardiotoxicity: JACC: CardioOncology Primer","volume":"3","author":"Zhang","year":"2021","journal-title":"JACC CardioOncol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1393631\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T13:25:45Z","timestamp":1727357145000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1393631\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,10]]},"references-count":44,"alternative-id":["10.3389\/fcvm.2024.1393631"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2024.1393631","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,10]]},"article-number":"1393631"}}